Multi-center, open-label, uncontrolled study to assess contraceptive efficacy and safety of Mirena during extended use beyond 5 years in women 18 to 35 years of age including a subgroup evaluation of treatment effect on heavy menstrual bleeding

Investigator: Philip Darney, MD, MS
Sponsor: Bayer HealthCare Pharmaceuticals, Inc

Location(s): United States


no description